Nasdaq: CHRWC.H. Robinson

    C.H. Robinson lifts revolving credit to $1.25 billion, extends it to 2031

    • US stocks
    • Agreement
    • Industrials
    Two sides of a silver 1874 US trade dollar coin, one showing a seated allegorical figure and the other an eagle.
    Windrain, via Wikimedia Commons (CC0). Illustrative image.

    C.H. Robinson (Nasdaq: CHRW) amended its credit agreement on 2 Nov 2026, raising aggregate revolving commitments from $1.0 billion to $1.25 billion and extending the facility to 31 Oct 2031. The company said it on 4 Nov 2026 that the changes accommodate its acquisition of RXO, Inc.

    Key highlights

    • Revolving commitments: $1.25 billion, up from $1.0 billion
    • Revolving facility maturity: 31 Oct 2031, previously 19 Nov 2027
    • Accordion facility: $625 million, up from $500 million
    • Leverage holidays permitted: three, up from two
    • Interest rate margins: unchanged, from 0.75% to 1.375%

    The amendment in numbers

    ItemDetail
    Agent bankU.S. Bank National Association
    Revolving commitments$1.25 billion, from $1.0 billion
    Letter of credit sublimit$150 million, from $50 million
    Accordion facility$625 million, from $500 million
    Revolving facility maturity31 Oct 2031, from 19 Nov 2027
    Judgment default and material indebtedness thresholds$200 million, from $125 million
    Cap on certain EBITDA add-backs15% of consolidated EBITDA
    Interest rate margins and commitment feesUnchanged: margins 0.75% to 1.375%, fees 0.07% to 0.15%

    The facility grows and its maturity moves out

    The amendment, dated 2 Nov 2026, extends the revolving credit facility's maturity from 19 Nov 2027 to 31 Oct 2031. It raises aggregate revolving commitments from $1.0 billion to $1.25 billion, and the letter of credit sublimit from $50 million to $150 million. The accordion facility rises from $500 million to $625 million.

    The amendment also raises the monetary judgment default and material indebtedness thresholds from $125 million to $200 million. It permits subsidiary guarantors to be released when certain conditions are met, including release under the note purchase agreement and other material indebtedness.

    New add-backs and leverage holidays

    New add-backs cover unusual cash charges, restructuring and deal costs, and expected savings from acquisitions the facility permits. The filing says certain of these add-backs are capped at 15% of consolidated EBITDA for any period.

    The number of permitted leverage holidays rises from two to three. A leverage holiday lets the company raise its maximum leverage ratio to 4.25 to 1.00 for four fiscal quarters after a permitted acquisition. The filing says one will be deemed elected on completion of the RXO acquisition.

    A companion amendment to the note purchase agreement, also dated 2 Nov 2026, raises the cross-default thresholds to $200 million. During a leverage holiday, the notes carry a higher interest rate: 0.75% a year when leverage is above 3.75 to 1.00 and up to 4.00 to 1.00, and 1.25% a year above 4.00 to 1.00.

    Part of the bridge facility commitments was terminated

    A portion of the Bridge Facility commitments under a commitment letter dated 4 Oct 2026 with Morgan Stanley Senior Funding, Inc. was terminated once the note purchase agreement amendment and a previously disclosed fifth amendment took effect, and the related backstop fees were reduced correspondingly.

    What the amendment means for C.H. Robinson shareholders

    The changes concern the company's borrowing terms rather than its share count. The filing does not say whether the company has drawn on the facilities, what the RXO acquisition will cost, or when it is expected to close.

    The filing does not give the amount of the backstop fee reduction.

    Filed with the US SEC on . Reference: Original filing (SEC)

    Disclaimer:

    The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.

    Figures are from the company's filings with the US Securities and Exchange Commission and are in US dollars. Investing in US stocks from India is subject to the Liberalised Remittance Scheme, currency risk and taxes in both countries.

    Latest posts